Cargando…

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota

BACKGROUND: Obesity is a major risk factor for a variety of diseases such as diabetes, nonalcoholic fatty liver disease, and cardiovascular diseases. Restricting energy intake, or caloric restriction (CR), can reduce body weight and improve metabolic parameters in overweight or obese patients. We pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Meng-Ting, Huang, Ying-Juan, Zhang, Ting-Ying, Tan, Lun-Bo, Lu, Xi-Feng, Qin, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658390/ https://www.ncbi.nlm.nih.gov/pubmed/31367159 http://dx.doi.org/10.3748/wjg.v25.i27.3590

Ejemplares similares

Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats
por: Ning, Ying, et al.
Publicado: (2022)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling
por: Li, Xueping, et al.
Publicado: (2019)

Obesity-Associated Hepatosteatosis and Impairment of Glucose Homeostasis Are Attenuated by Haptoglobin Deficiency
por: Lisi, Simonetta, et al.
Publicado: (2011)

Differences in metabolic improvement after metabolic surgery are linked to the gut microbiota in non-obese diabetic rats
por: Luo, Xin, et al.
Publicado: (2023)

Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
por: Yang, Fuyuan, et al.
Publicado: (2022)

Erratum to “Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease”
por: Yang, Fuyuan, et al.
Publicado: (2022)

Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
por: Ye, Jian-Zhong, et al.
Publicado: (2018)

Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits
por: Xing, Ya-Wei, et al.
Publicado: (2019)

Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects☆
por: Xi, Feifei, et al.
Publicado: (2012)

Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation
por: Wen, Xin, et al.
Publicado: (2021)

Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway
por: Wu, Yan-Li, et al.
Publicado: (2019)

Qingyi decoction attenuates intestinal epithelial cell injury via the calcineurin/nuclear factor of activated T-cells pathway
por: Wang, Guan-Yu, et al.
Publicado: (2022)

Optimal dosing time of Dachengqi decoction for protection of extrapancreatic organs in rats with experimental acute pancreatitis
por: Yao, Jia-Qi, et al.
Publicado: (2020)

Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice
por: Velázquez, Kandy T, et al.
Publicado: (2019)

Gut microbiota profile in healthy Indonesians
por: Rahayu, Endang Sutriswati, et al.
Publicado: (2019)

Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion
por: Yang, Lili, et al.
Publicado: (2017)

Optimal immunosuppressor induces stable gut microbiota after liver transplantation
por: Jiang, Jian-Wen, et al.
Publicado: (2018)

Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial
por: Xu, Jingjuan, et al.
Publicado: (2020)

Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat diet-induced obesity by modulating gut microbiome and lipid metabolism
por: Ai, Zi-Li, et al.
Publicado: (2022)

Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation
por: Zheng, Lie, et al.
Publicado: (2017)

Ji-Chuan decoction ameliorates slow transit constipation via regulation of intestinal glial cell apoptosis
por: Wang, Xiu-Min, et al.
Publicado: (2022)

Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice
por: Wang, Xin, et al.
Publicado: (2017)

Xiaojianzhong decoction prevents gastric precancerous lesions in rats by inhibiting autophagy and glycolysis in gastric mucosal cells
por: Zhang, Jia-Xiang, et al.
Publicado: (2023)

Gut mucosal microbiota profiles linked to colorectal cancer recurrence
por: Huo, Rui-Xue, et al.
Publicado: (2022)

Effect of low-dose radiation on thyroid function and the gut microbiota
por: Tong, Jun-Yu, et al.
Publicado: (2022)

New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism
por: Jiang, Xian-Wan, et al.
Publicado: (2020)

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease
por: Liu, Tao, et al.
Publicado: (2013)

Dachaihu decoction ameliorates pancreatic fibrosis by inhibiting macrophage infiltration in chronic pancreatitis
por: Duan, Li-Fang, et al.
Publicado: (2017)

Correlation between gut microbiota and glucagon-like peptide-1 in patients with gestational diabetes mellitus
por: Liang, Yun-Yi, et al.
Publicado: (2022)

Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
por: Yan, Bao-Fei, et al.
Publicado: (2023)

Characteristics of mucosa-associated gut microbiota during treatment in Crohn’s disease
por: He, Cong, et al.
Publicado: (2019)

Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea
por: Li, Yan-Dong, et al.
Publicado: (2021)

Modified lingguizhugan decoction incorporated with dietary restriction and exercise ameliorates hyperglycemia, hyperlipidemia and hypertension in a rat model of the metabolic syndrome
por: Yao, Limei, et al.
Publicado: (2017)

Phytochemical Analysis Using UPLC-MS/MS Combined with Network Pharmacology Methods to Explore the Biomarkers for the Quality Control of Lingguizhugan Decoction
por: Li, Baolin, et al.
Publicado: (2021)

Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe(−/−) Mice
por: Lindskog Jonsson, Annika, et al.
Publicado: (2018)

Investigating of Moringa Oleifera Role on Gut Microbiota Composition and Inflammation Associated with Obesity Following High Fat Diet Feeding
por: Elabd, Elham M. Youssef, et al.
Publicado: (2018)

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
por: Bajer, Lukas, et al.
Publicado: (2017)

Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer via the nuclear factor-κB-myosin light chain kinase-myosin light chain pathway
por: Lu, Yue, et al.
Publicado: (2018)

Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats
por: Yu, Zhi-Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9n9pglu07542kk4kffonviq3i8